Cidara Therapeutics Inc. (NASDAQ: CDTX) Stock Information | RedChip

Cidara Therapeutics Inc. (NASDAQ: CDTX) Listen to this Section


$12.50
-0.1400 ( -1.11% ) 11.7K

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Market Data


Open


$12.50

Previous close


$12.64

Volume


11.7K

Market cap


$90.02M

Day range


$12.45 - $12.83

52 week range


$10.00 - $24.40

Insider Ownership Transactions

Total Amount Purchased: -722,205.00 | $ -9,027,562.50

Date Type Amount Purchased Purchaser
2024-07-22 Sale -703080.00 RA CAPITAL MANAGEMENT, L.P.
2024-07-19 Sale -2125.00 BURGESS DANIEL D
2024-07-19 Sale -2125.00 Bassler Bonnie L
2024-07-19 Sale -2125.00 Schroeder Theodore R
2024-07-19 Sale -2125.00 Spencer Ryan
2024-07-19 Sale -2125.00 Mineo Chrysa
2024-07-19 Sale -2125.00 Merson James
2024-07-19 Sale -2125.00 Tadvalkar Laura
2024-07-19 Sale -2125.00 RA CAPITAL MANAGEMENT, L.P.
2024-07-19 Sale -2125.00 Canale-Theakston Carin

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 83 Aug 13, 2024
8-k 8K-related 15 Aug 13, 2024
4/a Other 1 Jul 22, 2024
4 Insider transactions 1 Jul 22, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.